ZEGFROVY® now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations 22 October
TEZSPIRE positive results from Phase III CROSSING trial in eosinophilic esophagitis including symptom improvement, histologic and endoscopic remission presented at United European Gastroenterology Week 20 October
AstraZeneca to present overall survival data from four pivotal Phase III trials in Presidential Symposia at ESMO 2026 featuring Sone-Ve, IMFINZI® , TAGRISSO® and savolitinib 19 October
